The PCPT trial

The PCPT trial

Toon andere (2) versies

The PCPT trial is the first phase III trial with the principal objective of examining the hypothesis that the use of chemoprevention could prevent the development of prostate cancer. This is a large scale randomised clinical trial comparing finasteride (5-α reductase inhibitor) to placebo. A total o...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Hamdy, F, Rouprêt, M
Formaat:	Journal article
Taal:	French
Gepubliceerd in:	2008

Gelijkaardige items

[The PCPT trial].
door: Hamdy, F, et al.
Gepubliceerd in: (2008)

The PCPT trial
door: Hamdy, F, et al.
Gepubliceerd in: (2008)

Estimating Hydraulic Conductivity of Overconsolidated Soils Based on Piezocone Penetration Test (PCPT)
door: Binyam M. Bekele, et al.
Gepubliceerd in: (2021-02-01)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT)/
door: 207490 Ismail Bakar, et al.
Gepubliceerd in: (1981)

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
door: Ankerst, D, et al.
Gepubliceerd in: (2012)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT) / [mikrofilem]
door: 207490 Ismail Bakar

A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort
door: Samuel Carbunaru, et al.
Gepubliceerd in: (2019-11-01)

Time-dependent behavior of full-scale precast post-tensioned (PCPT) girders: Experimental and finite element analysis
door: Panuwat Joyklad, et al.
Gepubliceerd in: (2022-12-01)

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
door: Enrique Gomez Gomez, et al.
Gepubliceerd in: (2019-11-01)

Correction: Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
Gepubliceerd in: (2020-02-01)

Prostate cancer risk calculators – PBCG vs. PCPT 2.0: Which one should we use when it comes to clinical decision-making?
door: A.B. Silva, et al.
Gepubliceerd in: (2020-11-01)

PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL
door: Christiano Tansol, et al.
Gepubliceerd in: (2017-07-01)

Becoming editor-in-chief of European Urology Oncology: The 4 pillars of the development strategy
door: M. Rouprêt
Gepubliceerd in: (2023-11-01)

Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature.
door: Yates, DR, et al.
Gepubliceerd in: (2013)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
door: Rouprêt, M, et al.
Gepubliceerd in: (2005)

The prostate cancer prevention trial and its messages.
door: Hamdy, F
Gepubliceerd in: (2007)

Clinically localised prostate cancer is microsatellite stable.
door: Azzouzi, A, et al.
Gepubliceerd in: (2007)

Word of wisdom. Re: mortality results from the Goteborg randomised population-based prostate-cancer screening trial.
door: Hamdy, F
Gepubliceerd in: (2010)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
door: Rouprêt, M, et al.
Gepubliceerd in: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
door: Roupret, M, et al.
Gepubliceerd in: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
door: Roupret, M, et al.
Gepubliceerd in: (2007)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
door: Hamdy, F, et al.
Gepubliceerd in: (2003)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
door: Elisabeth Grobet-Jeandin, et al.
Gepubliceerd in: (2021-10-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
door: Roupret, M, et al.
Gepubliceerd in: (2004)

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
door: Rouprêt, M, et al.
Gepubliceerd in: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
door: Roupret, M, et al.
Gepubliceerd in: (2007)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
door: Elliott, D, et al.
Gepubliceerd in: (2017)

Robot-assisted laparoscopic artificial urinary sphincter insertion in women with stress urinary incontinence: A pilot single-center study
door: E. Chartier-Kastler, et al.
Gepubliceerd in: (2020-07-01)

Addressing patient treatment preferences at trial recruitment.
door: Mills, N, et al.
Gepubliceerd in: (2011)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
door: Lane, J, et al.
Gepubliceerd in: (2009)

[Early diagnosis and surgical management of prostate cancer]
door: Linton, D, et al.
Gepubliceerd in: (2004)

Early diagnosis and surgical management of prostate cancer
door: Linton, D, et al.
Gepubliceerd in: (2004)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
door: Donovan, J, et al.
Gepubliceerd in: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
door: Lane, J, et al.
Gepubliceerd in: (2007)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
door: Mills, N, et al.
Gepubliceerd in: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
door: Mills, N, et al.
Gepubliceerd in: (2011)

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.
door: Mills, N, et al.
Gepubliceerd in: (2003)

Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study)
door: Alae Touzani, et al.
Gepubliceerd in: (2022-11-01)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
door: Lane, J, et al.
Gepubliceerd in: (2004)

In defense of randomized clinical trials in surgery: Let us not forget Archie Cochrane's legacy.
door: Catto, J, et al.
Gepubliceerd in: (2017)